Atea Pharmaceuticals, Inc. Common Stock

AVIRNASDAQ • USD
4.12 USD
↘ 0.18 (4.19%)AT CLOSE (03:59 PM EST)
4.15
↗ 0.02 (0.61%)
POST MARKET (AS OF 05:29 PM EST)
Post Market
AS OF 05:29 PM EST
4.15
↗ 0.02 (0.61%)
🟢Market: OPEN

Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.15 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$4.33
High?$4.38
Low?$4.10
Prev. Close?$4.30
Volume?310.6K
Avg. Volume?298.0K
VWAP?$4.22
Rel. Volume?1.04x
Bid / Ask
Bid?$3.51 × 100
Ask?$4.76 × 100
Spread?$1.25
Midpoint?$4.14
Valuation & Ratios
Market Cap?345.3M
Shares Out?80.3M
Float?61.1M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?1.97
EPS?-$1.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
345.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
38
Momentum?
77
Short Sent.?
63
Piotroski F-Score?0/9Weak
Altman Z-Score?2.08Grey
Confidence?50%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.92%Low
Short Interest?3.0M
Days to Cover?9.6
Free Float61.1M
Avg Daily Volume315.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.00Strong
Quick Ratio?8.00Strong
Cash Ratio?3.91Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
75
1.97CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-88.5%WEAK▾
ROA?
S&P
3
-77.4%WEAK▾
Cash Flow & Enterprise
FCF?$-140572000
Enterprise Value?$247.4M
Fundamentals ratios updated end of day